Etomidate Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection/Emulsion

Available Strengths: 2 mg/mL

Reference Brands: Amidate(US); Etomidate-Lipuro(EU)

Category: Critical Care

Etomidate is a fast-acting IV anesthetic used for induction and emergency intubation, available in 2 mg/mL strength. Leading brands include Amidate, Etomidate-Lipuro, and Hameln. A key ICU and OR medication, Etomidate is widely sourced via pharma B2B platforms for hospitals, emergency departments, and critical care units. Etomidate is available in Intravenous (IV) Injection/Emulsion and strengths such as 2 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Etomidate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Etomidate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Etomidate is a rapid-onset intravenous anesthetic agent used primarily for the induction of general anesthesia and rapid sequence intubation (RSI), particularly in hemodynamically unstable patients. It is available as a 2 mg/mL solution in 10 mL and 20 mL vials, ampoules, or pre-filled syringes. In the US, Etomidate is marketed under the brand name Amidate by Pfizer, along with generics from Baxter, Hikma, and others. In the EU, Etomidate-Lipuro by B. Braun and Hameln brands are widely distributed. Etomidate is a critical care medication supplied through pharma B2B platforms to hospitals, emergency units, and surgical centers worldwide.